Weiwei Nie

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

The expression status of TRX, AR, and cyclin D1 correlates with clinicopathological characteristics and ER status in breast cancer.

The expression status of TRX, AR, and cyclin D1 correlates with clinicopathological characteristics and ER status in breast cancer.

Journal: OncoTargets and therapy

Published: August 09, 2016

TXNIP interaction with the Her-1/2 pathway contributes to overall survival in breast cancer.

TXNIP interaction with the Her-1/2 pathway contributes to overall survival in breast cancer.

Journal: Oncotarget

Published: November 07, 2014

miR-1470 mediates lapatinib induced p27 upregulation by targeting c-jun.

miR-1470 mediates lapatinib induced p27 upregulation by targeting c-jun.

Journal: Journal of cellular physiology

Published: September 16, 2014

Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation in human breast cancer.

Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation in human breast cancer.

Journal: Oncotarget

Published: July 30, 2014

Lin28B expression correlates with aggressive clinicopathological characteristics in breast invasive ductal carcinoma.

Lin28B expression correlates with aggressive clinicopathological characteristics in breast invasive ductal carcinoma.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: June 03, 2014

MicroRNA-495 induces breast cancer cell migration by targeting JAM-A.

MicroRNA-495 induces breast cancer cell migration by targeting JAM-A.

Journal: Protein & cell

Published: April 14, 2014

The regulatory loop of COMP1 and HNF-4-miR-150-p27 in various signaling pathways.

The regulatory loop of COMP1 and HNF-4-miR-150-p27 in various signaling pathways.

Journal: Oncology letters

Published: February 16, 2014

TCF7L2 rs12255372 (G>T) polymorphism contributes to breast carcinogenesis: evidence from a meta-analysis.

TCF7L2 rs12255372 (G>T) polymorphism contributes to breast carcinogenesis: evidence from a meta-analysis.

Journal: Critical reviews in eukaryotic gene expression

Published: November 26, 2013

Multitargeted antiangiogenic tyrosine kinase inhibitors combined to chemotherapy in metastatic breast cancer: a systematic review and meta-analysis.

Multitargeted antiangiogenic tyrosine kinase inhibitors combined to chemotherapy in metastatic breast cancer: a systematic review and meta-analysis.

Journal: European journal of clinical pharmacology

Published: November 08, 2013

Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.

Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: August 13, 2013

Risk of hypertension with regorafenib in cancer patients: a systematic review and meta-analysis.

Risk of hypertension with regorafenib in cancer patients: a systematic review and meta-analysis.

Journal: European journal of clinical pharmacology

Published: July 31, 2013

3' untranslated region 1630 C>T polymorphism of prohibitin increases risk of breast cancer.

3' untranslated region 1630 C>T polymorphism of prohibitin increases risk of breast cancer.

Journal: OncoTargets and therapy

Published: March 08, 2013

Showing 1-12 of 17

Last Updated: 09/26/2026